ProfileGDS4718 / 211724_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 86% 84% 86% 85% 91% 92% 87% 84% 85% 89% 87% 94% 92% 92% 88% 85% 91% 91% 85% 88% 87% 86% 88% 87% 90% 85% 91% 87% 91% 89% 90% 84% 86% 89% 91% 92% 87% 86% 84% 84% 89% 90% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8780788
GSM549102patient 115, normal, homogenized [OPG study]8.5196786
GSM549104patient 119, normal, homogenized [OPG study]8.4677484
GSM549108patient 138, normal, homogenized [OPG study]8.5103686
GSM549119patient 077, normal, homogenized [OPG study]8.4240685
GSM549133patient 032, cancer, homogenized [OPG study]9.392891
GSM549139patient 042, cancer, homogenized [OPG study]9.4850492
GSM549099patient 107, normal, homogenized [OPG study]8.6813587
GSM549109patient 139, normal, homogenized [OPG study]8.2876584
GSM549110patient 046, normal, homogenized [OPG study]8.5273185
GSM549114patient 063, normal, homogenized [OPG study]9.1167889
GSM549122patient 082, normal, homogenized [OPG study]8.7450287
GSM549134patient 033, cancer, homogenized [OPG study]9.9115494
GSM549136patient 036, cancer, homogenized [OPG study]9.602692
GSM549140patient 044, cancer, homogenized [OPG study]9.5074292
GSM549111patient 047, normal, homogenized [OPG study]8.9925588
GSM549113patient 057, normal, homogenized [OPG study]8.6616585
GSM549132patient 031, cancer, homogenized [OPG study]9.4057991
GSM549137patient 038, cancer, homogenized [OPG study]9.3390191
GSM549142patient 047, cancer, homogenized [OPG study]8.12785
GSM549100patient 110, normal, homogenized [OPG study]8.9170688
GSM549107patient 135, normal, homogenized [OPG study]8.731987
GSM549115patient 068, normal, homogenized [OPG study]8.8098786
GSM549116patient 072, normal, homogenized [OPG study]8.9686688
GSM549120patient 078, normal, homogenized [OPG study]8.7317787
GSM549131patient 030, cancer, homogenized [OPG study]9.2842290
GSM549118patient 074, normal, homogenized [OPG study]8.5019185
GSM549129patient 027, cancer, homogenized [OPG study]9.2266991
GSM549123patient 088, normal, homogenized [OPG study]8.6930687
GSM549124patient 006, cancer, homogenized [OPG study]9.2095891
GSM549126patient 015, cancer, homogenized [OPG study]8.9887489
GSM549128patient 025, cancer, homogenized [OPG study]9.2377790
GSM549103patient 117, normal, homogenized [OPG study]8.1440184
GSM549117patient 073, normal, homogenized [OPG study]8.7419386
GSM549138patient 041, cancer, homogenized [OPG study]9.1056789
GSM549141patient 045, cancer, homogenized [OPG study]9.4543891
GSM549130patient 028, cancer, homogenized [OPG study]9.3659192
GSM549101patient 111, normal, homogenized [OPG study]8.7359187
GSM549105patient 128, normal, homogenized [OPG study]8.5192686
GSM549106patient 134, normal, homogenized [OPG study]8.5449384
GSM549112patient 048, normal, homogenized [OPG study]8.3650684
GSM549125patient 011, cancer, homogenized [OPG study]8.8937689
GSM549127patient 024, cancer, homogenized [OPG study]9.055690
GSM549135patient 035, cancer, homogenized [OPG study]9.9284194